NIDAN — Nidan Laboratories and Healthcare Cashflow Statement
0.000.00%
- IN₹278.00m
- IN₹334.13m
- IN₹241.77m
- 51
- 64
- 14
- 38
Annual cashflow statement for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 7.15 | 33 | 45.2 | 48.1 | -23.7 |
Depreciation | |||||
Non-Cash Items | 37.4 | 33.6 | 19 | 19.5 | 63.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -30.3 | -55.1 | -12.3 | 40.3 | -217 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 46.2 | 43.5 | 78.3 | 139 | -149 |
Capital Expenditures | -0.088 | -32.2 | -70.7 | -6.68 | -7.36 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0 | -287 | -23.2 | 106 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.088 | -32.2 | -357 | -29.9 | 98.4 |
Financing Cash Flow Items | -37.4 | -33.6 | -24.4 | -22.2 | -19.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -15.6 | -12.2 | 287 | -106 | -4.87 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 30.5 | -0.964 | 8.05 | 3.18 | -55.7 |